Anti-alpha-enolase antibodies in pituitary disease

Endocr J. 2003 Dec;50(6):697-702. doi: 10.1507/endocrj.50.697.

Abstract

A previous study reported a high prevalence of autoantibodies to alpha-enolase in lymphocytic hypophysitis and these antibodies efficiently distinguished lymphocytic hypophysitis from pituitary tumors. To confirm this, we examined autoantibodies to alpha-enolase in patients with lymphocytic hypophysitis (n = 17), pituitary non-functioning adenoma (n = 13), other pituitary diseases (n = 17) and other autoimmune diseases (n = 30), and compared to healthy controls (n = 46). Autoantibodies were found in 41.2%, 46.2%, 23.5%, 20.0% and 4.3%, respectively. Our findings indicate that detection of anti-alpha-enolase antibodies is not suitable for specific diagnosis of lymphocytic hypophysitis.

Publication types

  • Evaluation Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenoma / diagnosis
  • Adenoma / immunology
  • Adult
  • Autoantibodies / blood*
  • Autoimmune Diseases / diagnosis
  • Autoimmune Diseases / immunology*
  • Biomarkers, Tumor
  • DNA-Binding Proteins / immunology*
  • Diagnosis, Differential
  • Female
  • Humans
  • Inflammation / diagnosis
  • Inflammation / immunology
  • Lymphocytes / immunology
  • Male
  • Middle Aged
  • Phosphopyruvate Hydratase / immunology*
  • Pituitary Diseases / diagnosis
  • Pituitary Diseases / enzymology*
  • Pituitary Diseases / immunology*
  • Pituitary Neoplasms / diagnosis
  • Pituitary Neoplasms / immunology
  • Tumor Suppressor Proteins / immunology*

Substances

  • Autoantibodies
  • Biomarkers, Tumor
  • DNA-Binding Proteins
  • Tumor Suppressor Proteins
  • ENO1 protein, human
  • Phosphopyruvate Hydratase